Journal
FOOD AND CHEMICAL TOXICOLOGY
Volume 149, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.fct.2021.111997
Keywords
Mangiferin; Inflammation; Cancer; Toxicity; Molecular mechanism; Intestinal barrier
Categories
Funding
- Jiangsu Specially-Appointed Professor Program [19TPJS-002]
- Senior Talent Startup Fund of Jiangsu University [4111360002]
Ask authors/readers for more resources
Mangiferin, a C-glycosyl xanthone, has potential pharmacological activities in attenuating inflammation and preventing cancer by inhibiting inflammatory mediators, protecting intestinal barrier integrity, and targeting molecular pathways. Understanding the molecular targets of mangiferin is crucial for its better application in treating inflammation-related diseases and preventing cancer.
Chronic inflammation is crucial for the pathological process of tumors due to increasing the infiltration of cytokines, growth factors, and chemokines to the tumor microenvironment. Phenolic compounds are considered natural remedies for inflammation and cancer. Mangiferin is a C-glycosyl xanthone that possesses numerous pharmacological activities. It has the potential to attenuate inflammation in different organs through the mechanisms of inhibiting pattern recognition receptors, regulating cell signaling pathways, activating autophagy, inhibiting the secretion of inflammatory mediators, and protecting intestinal barrier integrity, which in turn prevents cancer. In this review, the recent advances in the anti-inflammation and anti-cancer mechanisms of mangiferin as well as its safety and toxicity were summarized. The impacts of modified mangiferin and the synergic effects with other components were also discussed. Understanding the molecular targets of mangiferin is of great significance for its better application in the amelioration of inflammation-related diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available